Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it.
OBJECTIVE
This article is a primer in conducting an imaging-guided percutaneous renal ablation program based on the clinical experience of three institutions.


CONCLUSIONS
Imaging-guided percutaneous ablation is becoming a viable alternative to surgery for the management of locally confined renal cell carcinoma. Conducting a successful renal tumor ablation program includes understanding the treatment options for early-stage renal cell carcinoma, selecting the appropriate patients, understanding the procedural techniques, and organizing a comprehensive follow-up.
Uppot
Raul N
RN
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, 02114, USA. ruppot@partners.org
Silverman
Stuart G
SG
Zagoria
Ronald J
RJ
Tuncali
Kemal
K
Childs
David D
DD
Gervais
Debra A
DA
D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D003452:Cryosurgery / Q000379:methods*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D025321:Surgery, Computer-Assisted / Q000379:methods*